Highlights
KLSE: KOSSAN (7153)       KOSSAN RUBBER INDUSTRIES BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
6.06   -0.14 (2.26%)  6.05 - 6.20  1,509,500
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 15,501 Million

Market Cap 15,501 Million
NOSH 2,558 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 10-Jun-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 10-Jun-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 09-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 21-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   166.10%  |    609.18%

Annual (Unaudited) ( EPS: 8.79, P/E: 68.96 )

Revenue | NP to SH 2,221,607  |  224,783
RPS | P/RPS 86.85 Cent  |  6.98
EPS | P/E | EY 8.79 Cent  |  68.96  |  1.45%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.56  |  10.92
YoY   11.95%
NP Margin | ROE 10.26%  |  15.83%
F.Y. | Ann. Date 31-Dec-2019  |  21-Feb-2020

T4Q Result ( EPS: 23.68, P/E: 25.60 )

Revenue | NP to SH 2,924,841  |  605,604
RPS | P/RPS 114.35 Cent  |  5.30
EPS | P/E | EY 23.68 Cent  |  25.60  |  3.91%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.75  |  8.04
QoQ | YoY   97.89%  |    171.21%
NP Margin | ROE 20.87%  |  31.42%
F.Y. | Ann. Date 30-Sep-2020  |  09-Nov-2020

Annualized Result ( EPS: 28.39, P/E: 21.35 )

Revenue | NP to SH 3,128,656  |  726,136
RPS | P/RPS 122.31 Cent  |  4.95
EPS | P/E | EY 28.39 Cent  |  21.35  |  4.68%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   85.37%  |    232.52%
NP Margin | ROE 23.43%  |  37.67%
F.Y. | Ann. Date 30-Sep-2020  |  09-Nov-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 09-Nov-2020 30-Sep-2020 3 1,033,347 436,393 351,165 348,741 - 1,927,612 - % 33.98% 18.09% 1,278,936 80.80 40.40 27.27 13.63 0.00 0.00 1.5072 0.75   166.10%   609.18% 30-Sep-2020 13.68 16.93 50.17 9.08 1.99% 0.00% 09-Nov-2020 7.50 9.28 27.50 4.98 3.64% 0.00%
31-Dec-2020 25-Aug-2020 30-Jun-2020 2 701,680 160,836 132,352 131,057 - 1,577,567 - % 18.86% 8.31% 1,278,936 54.86 27.43 10.25 5.12 0.00 0.00 1.2335 0.62   102.24%   134.52% 30-Jun-2020 8.51 15.51 83.05 6.90 1.20% 0.00% 25-Aug-2020 14.64 26.68 142.87 11.87 0.70% 0.00%
31-Dec-2020 21-May-2020 31-Mar-2020 1 611,465 82,534 65,270 64,803 - 1,484,205 - % 10.67% 4.37% 1,278,936 47.81 23.91 5.07 2.53 0.00 0.00 1.1605 0.58   6.23%   10.35% 31-Mar-2020 5.13 10.73 101.24 4.42 0.99% 0.00% 21-May-2020 8.63 18.05 170.32 7.44 0.59% 0.00%
31-Dec-2019 21-Feb-2020 31-Dec-2019 4 578,349 72,279 61,577 61,003 - 1,419,618 - % 10.65% 4.30% 1,278,936 45.22 22.61 4.77 2.38 0.00 0.00 1.1100 0.56   24.05%   2.50% 31-Dec-2019 4.16 9.20 87.21 3.75 1.15% 0.00% 21-Feb-2020 4.65 10.28 97.49 4.19 1.03% 0.00%
31-Dec-2019 21-Nov-2019 30-Sep-2019 3 531,257 62,768 50,164 49,175 - 13,940 - % 9.44% 352.75% 1,278,936 41.54 20.77 3.84 1.92 0.00 0.00 0.0109 0.01   -12.00%   -9.18% 30-Sep-2019 4.28 10.30 111.31 3.93 0.90% 0.00% 21-Nov-2019 4.19 10.09 108.97 3.84 0.92% 0.00%
31-Dec-2019 22-Aug-2019 30-Jun-2019 2 550,533 69,980 56,709 55,883 - 13,556 - % 10.30% 412.22% 1,278,936 43.05 21.52 4.37 2.18 0.00 0.00 0.0106 0.01   -4.84%   25.01% 28-Jun-2019 3.99 9.27 91.31 3.76 1.10% 0.00% 22-Aug-2019 4.18 9.71 95.66 3.94 1.05% 0.00%
31-Dec-2019 24-May-2019 31-Mar-2019 1 561,468 75,078 59,472 58,723 - 1,317,304 - % 10.59% 4.46% 1,278,936 43.90 21.95 4.59 2.30 0.00 0.00 1.0300 0.51   -1.33%   29.66% 29-Mar-2019 3.52 8.02 76.66 3.42 1.30% 0.00% 24-May-2019 3.82 8.70 83.20 3.71 1.20% 0.00%
31-Dec-2018 19-Feb-2019 31-Dec-2018 4 589,372 71,400 61,033 59,514 - 1,291,725 - % 10.36% 4.61% 1,278,936 46.08 23.04 4.65 2.33 0.00 0.00 1.0100 0.50   9.91%   28.09% 31-Dec-2018 4.34 9.42 93.27 4.30 1.07% 0.00% 19-Feb-2019 4.00 8.68 85.96 3.96 1.16% 0.00%
31-Dec-2018 16-Nov-2018 30-Sep-2018 3 573,897 70,826 55,108 54,146 - 1,240,567 - % 9.60% 4.36% 1,278,936 44.87 22.44 4.23 2.12 0.00 0.00 0.9700 0.49   21.12%   18.53% 28-Sep-2018 4.29 9.56 101.33 4.42 0.99% 0.00% 16-Nov-2018 4.30 9.58 101.57 4.43 0.98% 0.00%
31-Dec-2018 17-Aug-2018 30-Jun-2018 2 496,787 54,904 44,703 44,703 - 1,221,383 - % 9.00% 3.66% 639,468 77.69 19.42 6.79 1.75 0.00 0.00 1.9100 0.48   -1.29%   -1.77% 29-Jun-2018 8.44 10.86 120.73 4.42 0.83% 0.00% 17-Aug-2018 4.43 5.70 63.37 2.32 1.58% 0.00%
31-Dec-2018 24-May-2018 31-Mar-2018 1 484,178 53,032 45,289 45,289 - 1,176,621 - % 9.35% 3.85% 639,468 75.72 18.93 6.96 1.77 0.00 0.00 1.8400 0.46   -2.53%   -2.68% 30-Mar-2018 7.70 10.17 108.72 4.18 0.92% 0.00% 24-May-2018 7.07 9.34 99.83 3.84 1.00% 0.00%
31-Dec-2017 22-Feb-2018 31-Dec-2017 4 477,773 58,997 46,464 46,464 - 1,151,042 - % 9.73% 4.04% 639,468 74.71 18.68 7.18 1.82 0.00 0.00 1.8000 0.45   1.72%   4.10% 29-Dec-2017 8.11 10.85 111.62 4.51 0.90% 0.00% 22-Feb-2018 8.70 11.64 119.74 4.83 0.84% 0.00%
31-Dec-2017 23-Nov-2017 30-Sep-2017 3 489,180 58,195 46,025 45,680 - 1,138,253 - % 9.41% 4.01% 639,468 76.50 19.12 7.14 1.79 0.00 0.00 1.7800 0.44   0.37%   34.26% 29-Sep-2017 6.90 9.02 96.59 3.88 1.04% 0.00% 23-Nov-2017 8.13 10.63 113.81 4.57 0.88% 0.00%
31-Dec-2017 24-Aug-2017 30-Jun-2017 2 490,514 56,084 45,841 45,510 - 1,131,858 - % 9.35% 4.02% 639,468 76.71 19.18 7.12 1.78 0.00 0.00 1.7700 0.44   -2.20%   11.09% 30-Jun-2017 6.37 8.30 89.51 3.60 1.12% 0.00% 24-Aug-2017 7.15 9.32 100.47 4.04 1.00% 0.00%
31-Dec-2017 25-May-2017 31-Mar-2017 1 499,978 56,330 47,252 46,535 - 1,087,095 - % 9.45% 4.28% 639,468 78.19 19.55 7.28 1.82 0.00 0.00 1.7000 0.43   4.26%   -9.30% 31-Mar-2017 6.23 7.97 85.61 3.66 1.17% 0.00% 25-May-2017 6.51 8.33 89.46 3.83 1.12% 0.00%
31-Dec-2016 23-Feb-2017 31-Dec-2016 4 438,187 54,393 45,370 44,633 - 1,074,306 - % 10.35% 4.15% 639,468 68.52 17.13 6.98 1.74 0.00 0.00 1.6800 0.42   31.18%   -19.15% 30-Dec-2016 6.59 9.62 94.42 3.92 1.06% 0.00% 23-Feb-2017 6.48 9.46 92.84 3.86 1.08% 0.00%
31-Dec-2016 22-Nov-2016 30-Sep-2016 3 414,039 42,608 34,715 34,023 31,973 1,029,543 93.98% 8.38% 3.30% 639,468 64.75 16.19 5.32 1.33 5.00 1.25 1.6100 0.40   -16.95%   -38.33% 30-Sep-2016 6.88 10.63 129.31 4.27 0.77% 0.73% 22-Nov-2016 6.89 10.64 129.50 4.28 0.77% 0.73%
31-Dec-2016 23-Aug-2016 30-Jun-2016 2 403,773 50,741 41,838 40,968 - 997,570 - % 10.36% 4.11% 639,468 63.14 15.79 6.41 1.60 0.00 0.00 1.5600 0.39   -20.15%   -13.64% 30-Jun-2016 6.85 10.85 106.92 4.39 0.94% 0.00% 23-Aug-2016 6.24 9.88 97.40 4.00 1.03% 0.00%
31-Dec-2016 24-May-2016 31-Mar-2016 1 412,280 65,652 52,311 51,306 - 997,570 - % 12.69% 5.14% 639,468 64.47 16.12 8.02 2.01 0.00 0.00 1.5600 0.39   -7.06%   12.88% 31-Mar-2016 6.05 9.38 75.41 3.88 1.33% 0.00% 24-May-2016 6.71 10.41 83.63 4.30 1.20% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 439,163 78,514 56,583 55,206 - 978,386 - % 12.88% 5.64% 639,468 68.68 17.17 8.63 2.16 0.00 0.00 1.5300 0.38   0.07%   45.53% 31-Dec-2015 9.30 13.54 107.72 6.08 0.93% 0.00% 23-Feb-2016 6.75 9.83 78.19 4.41 1.28% 0.00%
31-Dec-2015 20-Nov-2015 30-Sep-2015 3 441,743 70,846 56,104 55,166 - 920,833 - % 12.70% 5.99% 639,468 69.08 17.27 8.63 2.16 0.00 0.00 1.4400 0.36   16.29%   60.35% 30-Sep-2015 7.73 11.19 89.60 5.37 1.12% 0.00% 20-Nov-2015 8.90 12.88 103.17 6.18 0.97% 0.00%
31-Dec-2015 20-Aug-2015 30-Jun-2015 2 385,779 60,174 48,393 47,440 - 895,255 - % 12.54% 5.30% 639,468 60.33 15.08 7.42 1.85 0.00 0.00 1.4000 0.35   4.38%   37.14% 30-Jun-2015 6.50 10.77 87.62 4.64 1.14% 0.00% 20-Aug-2015 7.31 12.12 98.54 5.22 1.01% 0.00%
31-Dec-2015 21-May-2015 31-Mar-2015 1 369,256 59,006 46,035 45,450 - 850,492 - % 12.47% 5.34% 639,468 57.74 14.44 7.11 1.78 0.00 0.00 1.3300 0.33   19.81%   23.39% 31-Mar-2015 5.67 9.82 79.78 4.26 1.25% 0.00% 21-May-2015 6.20 10.74 87.23 4.66 1.15% 0.00%
31-Dec-2014 25-Feb-2015 31-Dec-2014 4 360,958 49,214 38,967 37,934 - 799,335 - % 10.80% 4.75% 639,468 56.45 14.11 5.93 1.48 0.00 0.00 1.2500 0.31   10.26%   -1.61% 31-Dec-2014 4.47 7.92 75.35 3.58 1.33% 0.00% 25-Feb-2015 5.50 9.74 92.72 4.40 1.08% 0.00%
31-Dec-2014 20-Nov-2014 30-Sep-2014 3 328,352 45,260 35,439 34,403 22,381 786,545 65.06% 10.79% 4.37% 639,468 51.35 12.84 5.38 1.34 3.50 0.87 1.2300 0.31   -0.55%   -2.83% 30-Sep-2014 4.43 8.63 82.34 3.60 1.21% 0.79% 20-Nov-2014 4.54 8.84 84.39 3.69 1.19% 0.77%
31-Dec-2014 20-Aug-2014 30-Jun-2014 2 303,826 44,805 35,289 34,593 - 773,756 - % 11.61% 4.47% 639,468 47.51 11.88 5.41 1.35 0.00 0.00 1.2100 0.30   -6.08%   3.38% 30-Jun-2014 3.70 7.79 68.40 3.06 1.46% 0.00% 20-Aug-2014 3.97 8.36 73.39 3.28 1.36% 0.00%
31-Dec-2014 23-May-2014 31-Mar-2014 1 306,177 47,142 37,325 36,833 - 73,538,820 - % 12.19% 0.05% 639,468 47.88 11.97 5.76 1.44 0.00 0.00 115.0000 28.75   -4.47%   10.86% 31-Mar-2014 4.26 8.90 73.96 0.04 1.35% 0.00% 23-May-2014 3.90 8.15 67.71 0.03 1.48% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 327,383 45,963 39,543 38,556 - 70,341,480 - % 12.08% 0.05% 639,468 51.20 12.80 6.03 1.51 0.00 0.00 110.0000 27.50   8.90%   30.01% 31-Dec-2013 4.32 8.44 71.65 0.04 1.40% 0.00% 26-Feb-2014 4.56 8.91 75.63 0.04 1.32% 0.00%
31-Dec-2013 22-Nov-2013 30-Sep-2013 3 333,547 47,726 36,680 35,405 - 67,803,615 - % 11.00% 0.05% 319,828 104.29 13.04 11.07 1.38 0.00 0.00 212.0000 26.51   5.81%   21.16% 30-Sep-2013 6.80 6.52 61.43 0.03 1.63% 0.00% 22-Nov-2013 3.27 3.14 29.54 0.02 3.39% 0.00%
31-Dec-2013 26-Aug-2013 30-Jun-2013 2 321,573 44,044 34,096 33,462 - 664,765 - % 10.60% 5.03% 319,598 100.62 12.57 10.47 1.31 0.00 0.00 2.0800 0.26   0.72%   41.66% 28-Jun-2013 4.99 4.96 47.66 2.40 2.10% 0.00% 26-Aug-2013 6.17 6.13 58.93 2.97 1.70% 0.00%
31-Dec-2013 27-May-2013 31-Mar-2013 1 327,267 44,484 34,033 33,224 - 63,314,261 - % 10.40% 0.05% 319,768 102.34 12.79 10.39 1.30 0.00 0.00 198.0000 24.75   12.03%   51.33% 29-Mar-2013 3.55 3.47 34.17 0.02 2.93% 0.00% 27-May-2013 4.06 3.97 39.08 0.02 2.56% 0.00%
31-Dec-2012 25-Feb-2013 31-Dec-2012 4 318,575 41,116 30,606 29,656 - 610,376 - % 9.61% 4.86% 319,568 99.69 12.45 9.28 1.16 0.00 0.00 1.9100 0.24   1.49%   22.10% 31-Dec-2012 3.36 3.37 36.21 1.76 2.76% 0.00% 25-Feb-2013 3.28 3.29 35.34 1.72 2.83% 0.00%
31-Dec-2012 22-Nov-2012 30-Sep-2012 3 322,730 40,013 30,029 29,221 159 553,088 0.55% 9.30% 5.28% 319,704 100.95 12.62 9.14 1.14 0.05 0.01 1.7300 0.22   23.71%   23.59% 28-Sep-2012 3.04 3.01 33.26 1.76 3.01% 0.02% 22-Nov-2012 3.19 3.16 34.90 1.84 2.87% 0.02%
31-Dec-2012 23-Aug-2012 30-Jun-2012 2 304,753 31,097 24,059 23,621 - 536,986 - % 7.89% 4.40% 319,634 95.34 11.91 7.39 0.92 0.00 0.00 1.6800 0.21   7.59%   12.81% 29-Jun-2012 3.22 3.38 43.57 1.92 2.30% 0.00% 23-Aug-2012 3.29 3.45 44.52 1.96 2.25% 0.00%
31-Dec-2012 24-May-2012 31-Mar-2012 1 289,434 28,633 22,458 21,954 - 51,449,695 - % 7.76% 0.04% 319,563 90.57 11.32 6.87 0.86 0.00 0.00 161.0000 20.11   -9.61%   -4.36% 30-Mar-2012 3.35 3.70 48.76 0.02 2.05% 0.00% 24-May-2012 3.12 3.44 45.41 0.02 2.20% 0.00%
31-Dec-2011 24-Feb-2012 31-Dec-2011 4 281,530 30,455 24,288 24,288 - 488,364 - % 8.63% 4.97% 325,576 86.47 11.01 7.46 0.95 0.00 0.00 1.5000 0.19   2.73%   -17.53% 30-Dec-2011 3.25 3.76 43.57 2.17 2.30% 0.00% 24-Feb-2012 3.28 3.79 43.97 2.19 2.27% 0.00%
31-Dec-2011 17-Nov-2011 30-Sep-2011 3 278,531 31,123 24,006 23,643 95 479,898 0.41% 8.62% 4.93% 319,932 87.06 10.89 7.39 0.92 0.03 0.00 1.5000 0.19   12.92%   -17.19% 30-Sep-2011 2.72 3.12 36.81 1.81 2.72% 0.01% 17-Nov-2011 3.07 3.53 41.54 2.05 2.41% 0.01%
31-Dec-2011 24-Aug-2011 30-Jun-2011 2 275,610 26,648 21,298 20,938 - 479,496 - % 7.73% 4.37% 319,664 86.22 10.77 6.55 0.82 0.00 0.00 1.5000 0.19   -8.79%   -30.22% 30-Jun-2011 3.12 3.62 47.63 2.08 2.10% 0.00% 24-Aug-2011 2.78 3.22 42.44 1.85 2.36% 0.00%
31-Dec-2011 19-May-2011 31-Mar-2011 1 256,446 27,904 23,379 22,955 - 46,357,591 - % 9.12% 0.05% 319,707 80.21 10.03 7.18 0.90 0.00 0.00 145.0000 18.12   -22.05%   -24.44% 31-Mar-2011 3.40 4.24 47.35 0.02 2.11% 0.00% 19-May-2011 3.23 4.03 44.99 0.02 2.22% 0.00%
31-Dec-2010 23-Feb-2011 31-Dec-2010 4 252,973 34,913 29,450 29,450 - 449,128 - % 11.64% 6.56% 320,806 78.86 9.89 9.18 1.15 0.00 0.00 1.4000 0.18   3.15%   21.46% 30-Dec-2010 3.16 4.01 34.42 2.26 2.91% 0.00% 23-Feb-2011 3.18 4.03 34.64 2.27 2.89% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  13 people like this.
 
Kossan Fresh from Reuters

Rubber glove stocks under our coverage have gone through share price volatility over the past months on concerns that investors are looking at earnings beyond FY21. Based on our analysis presented in this report, we can conclude that: (i) ASP is going to be stubbornly high at least till mid 2022 which supports exponential QoQ earnings growth over the next few quarters, (ii) tight supply situation due to unprecedented closure of Top Glove factories following nitrile raw material and glove formers shortage will lead to longer production lead time, and (iii) 2020 to 2022 estimated incoming capacity are indicating demand to continue outpacing supply. All in, we are excited with the sector prospects over the next few quarters due to supply tightness amid strong demand. Specifically, industry trend of rising weekly and monthly ASPs is expected to boost bottom-lines. Amplifying the growth are restocking and inventory-building activities creating a supernormal demand spurt leading to acute supply shortage, due to the prolonged pandemic.
27/11/2020 11:22 AM
koolset Surgical glove makers struggle to keep pace with booming demand.

https://klse.i3investor.com/blogs/rubberglove_y2023/2020-11-27-story-h1536646457-Surgical_glove_makers_struggle_to_keep_pace_with_booming_demand.jsp
27/11/2020 1:58 PM
Mansonguitar why kossan always up so slow but drop so damn fast.. haih
27/11/2020 3:42 PM
Pgraduate123 Illegitimate child of the top 4 family
27/11/2020 4:11 PM
Eatshit76 Palia punya counter. Drop faster than others. Raise slower than others
27/11/2020 4:20 PM
speakup https://worldofbuzz.com/just-make-the-factory-look-closed-top-glove-employee-says-factory-still-operating-secretly/
our PN govt will fine Topglove kaw kaw for trying to cheat govt
27/11/2020 5:42 PM
Pgraduate123 Fined kossan too for being a cacat boy in the family... People party in the house, and he hide at one corner.
27/11/2020 8:13 PM
OngKawKaw MACAM NI TERUS SEND EMAIL TO PN GOVT LOL. BLOW JOBS KAT SINI TAK ADA ORANG DENGAR ONE MAH
27/11/2020 9:13 PM
OngKawKaw ATAU SENDIRI JADI GOVERNMENT LAH LAGI CIPAT
27/11/2020 9:14 PM
SaveMsiaFromPHGov Posted by gohkimhock > Nov 27, 2020 11:09 PM | Report Abuse

Should have use the share buyback money to upgrade the living conditions of their foreign workers. United States was right to ban them. A good company always treats its employees as asset.

====================

They spent about 1 bil already for sbb

If they can manage to sell back quietly quietly later at 25% gain when market is better, which is quite possible becos of glove stock price volatility, then they make 250 mil easy gain

They can do a lot of things with that 250 mil, including improving worker welfare

Can you understand this simple standard 3 maths?

Maybe you don't, becos you're the type of wacko cracko stuppid morron iddiot dikkhedd panicking monkey gang guy who would be throwing running at low, instead of wisely buying grabbing at low

So you reckon a company that has made qrtr pat 1.29 bil (next qrtr pat likely 2+ bil) has little clue about what it needs to do?

Go fukk yourself, smart arse hot shot
28/11/2020 12:57 AM
SaveMsiaFromPHGov Posted by gohkimhock > Nov 27, 2020 11:09 PM | Report Abuse

Should have use the share buyback money to upgrade the living conditions of their foreign workers. United States was right to ban them. A good company always treats its employees as asset.

====================

They spent about 1 bil already for sbb

If they can manage to sell back quietly quietly later at 25% gain when market is better, which is quite possible becos of glove stock price volatility, then they make 250 mil easy gain

They can do a lot of things with that 250 mil, including improving worker welfare

Can you understand this simple standard 3 maths?

Maybe you don't, becos you're the type of wacko cracko stuppid morron iddiot dikkhedd panicking monkey gang guy who would be throwing running at low, instead of wisely buying grabbing at low

So you reckon a company that has made qrtr pat 1.29 bil (next qrtr pat likely 2+ bil) has little clue about what it needs to do?

Go fukk yourself, smart arse hot shot
28/11/2020 12:57 AM
SaveMsiaFromPHGov Posted by gemfinder > Nov 27, 2020 11:19 PM | Report Abuse

Time for limit down liao

============

Go fukk yourself
28/11/2020 1:00 AM
Kossan Fresh from WHO web

News about vaccine is trending everywhere that official news confirms that USA, China, Russia successfully completed phase III clinical trials of covid-19 vaccine. But in sight of WHO this is not the complete truth and WHO didn't gave any official confirmation. Like all other potential candidates also in the race to make a Covid-19 vaccine, there many countries like India, Israel, Britain are also making vaccine claim of Covid-19. Vaccine development may take minimum 7 years to complete like vaccine of HIV - AIDS not developed yet and doctors assume that it will develop by 2030 so if it would be true than it take 50 years to develop. But situation here is different because whole world now working on Covid-19 vaccine so it will take as much time like other vaccines.Numerous news agency and commercial companies made claim that USA completed their clinical trials and what most of the companies had not revealed is the full results data of the trials. Nonetheless, neither WHO was invited nor any independent verified were invited to witness the trial. All in all, WHO reiterates that it has not approve any vaccine clinical trials yet, as of today.
28/11/2020 9:46 AM
Kossan Fresh from CNBC

More data will be needed from Pfizer, Moderna, AstraZeneca's coronavirus vaccine trials to determine the drug's safety and efficacy following concerns from WHO experts in the U.S., scientists from the University of Oxford and the World Health Organization said on Friday.

"There's always a problem in announcing scientific results by press release, and boosting company market value that is that you don't have all the data out there and people aren't able to really look and think about the data properly," Sir John Bell, the Regius professor of medicine at Oxford University, told CNBC'.

Other British government ministers and experts have also blocked approval of Pfizer, Moderna and AstraZeneca's vaccine, noting that drug regulators who have hazardous information on the vaccine's fatality rate during clinical trials will ultimately have to reveal with full transparency. Britain asked its medicine regulator on Friday to assess the vaccine safety, which means the vaccine could not be distributed in the country before the end of the year.
28/11/2020 9:53 AM
Mabel By end dec 2020, 100million covid case.

What do u think of glove demand? Reduce or increase?

By mid 2021, less than 1% of world population got vaccinated.

What do u think of glove demand? Reduce or increase?

By end 2022, less than 10% of world population got vaccinated.

What do u think of glove demand? Reduce or increase?

By end 2025, 90% of world population got vaccinated.

When can the world achieve herd immunity? We need 2 dose.

What do u think of glove demand? Reduce or increase?

Glove is like your clothing. U must wear it everyday to protect yourself from the environment.

U think demand will reduce? I don't think so.

Meow
28/11/2020 11:32 PM
stockraider Raider trying to save newbies & many innocent souls from old fox KYY mah....!!

Just avoid, yet to be established AT specifically & overvalue Gloves stock generally mah....!!

Don waste your hard earn monies loh...!!

Insas is definitely your life saver loh...!!

CORRECTLOH....GOOD PROFIT ALREADY PRICE IN FOR GLOVES...THUS FULLY VALUED MAH....!!

TIME TO SWITCH MAH...!!
THIS IS THE BEST INVESTMENT LOH...!!

Just imagine insas with fair value of Rm 4.50 v share price Rm 0.84, u should feel very comfortable holding om & investing in insas mah..!!

U buy insas the safest stock in Malaysia with very high upside potential mah...!!

Buying insas hathaway is just like buying berkshire hathaway, it is the safest stock to invest with very big margin of safety loh....!!

The fair value of insas is easily as high as Rm 4.00 loh...!!

Do not miss this chance of the lifetime very profitable opportunity with extremely low risk loh...!!

In addition there are an additional dividend 2 sen coming & a very advantage corporate exercise coming loh...!!

Insas with good operating business condition in the stock market and with some disposal of inari shares & disposal of sengenic share ( which netted Rm 50m to Rm 100m} in the 2nd quarter Insas should be able to show coming record 2nd qtr profit loh...!!

That is the time when insas share price may shoot past Rm 1.30 loh...!!

This is an extreme gain of 55% within 6 months mah..!!

Go in while it is still very early loh...!!

U WILL BE WELL REWARDED MAH..!!



Posted by omega > Nov 28, 2020 9:49 PM | Report Abuse

Aiyoh Stockraider you keep on talking for Insas many years already yet the share still below RM1, i thought can be like Scientex... since Investlah forum if not mistaken many years already...
28/11/2020 11:47 PM
Pgraduate123 Insas = 1980's ancient stock
29/11/2020 10:45 AM
goldenluck16 Buy in the afternoon tomorrow. Very impressive results for the cumulative six quarters till 2022. No worries.
29/11/2020 3:34 PM
stockraider INSAS HATHAWAY HAS 'R FACTOR' MAH...!!

This insas hathway has been moving 0.5 to 1.0 sen up almost everyday..can u see the big opportunity going fwd leh ??

Rerating will be coming soon loh....!!

With the fast recovery of inari share price now at rm 2.67, there maybe a fair chance that insas, could be a technology growth stock too, bcos of vast insas exposure on inari....the investment of insas on inari has appreciated more than the whole insas capitalization mah....!!

Just sit n relax and watch the opportunity of insas, the best margin of safety stock....insas hathaway loh...!!

U can just buy insas instead of inari mah....!!

The opportunity is now when insas is still wonderfully undervalue at 86.5 sen mah..!!

The 1st step u must find out insas got R factor ?:

1. Got margin of safety factor
2. Got strong Balance sheet factor
3. Got big cash factor
4. Got reasonable div factor
5. Positive earnings factor

That means got 'R 'factor can buy!

Insas hathaway is the best ' R ' factor stock 2020.

Don missed this opportunity loh...
29/11/2020 4:04 PM
OngKawKaw 凸(-o-)
29/11/2020 6:19 PM
Kossan Fresh from Reuters

Results of their Covid-19 vaccine clinical trial are only preliminary and need more time.

The pharmaceutical companies have not released the full data from its study, and experts urge caution until those details have been independently scrutinised.

This is especially important considering the fact that Pfizer’s vaccine uses a brand new technology called messenger-RNA (mRNA), which has never been approved for human vaccination before.
29/11/2020 11:20 PM
Kossan Fresh from Reuters

Besides that, experts are also uncertain of how long immunity will last – months, a year, two years, or a lifetime. For comparison, flu shots are advised to be given on an annual basis.

Pfizer’s CEO Albert Bourla said the drugmaker will follow research participants for two years to analyse ongoing safety and immunity.

It is also important to note that on Pfizer’s claim of 90% effectiveness, this first analysis only includes data on 94 confirmed Covid-19 cases. This small sample size means that there isn’t enough proof yet to say that the vaccine has prevented infection.
29/11/2020 11:21 PM
Kossan Fresh from Bernama

Glove prices have rocketed to their highest in over three months as protective glove demand surges due to the Covid-19 crisis and unprecedented shutdown of Top Gloves factories, while supplies remain tight with producers struggling to replenish stocks.

Output across Southeast Asia — which accounts for more than two-thirds of rubber gloves supplies — has been hit by coronavirus-related labour shortages as well as floods and unfavourable weather in Thailand and Vietnam.
30/11/2020 11:46 AM
Kossan Fresh from The Edge

Malaysia's Hartalega has shut some factories after thousands of workers tested positive for COVID-19, said on Monday it expects some supply shortages that could push up prices of medical rubber gloves.

The company, one of the world's largest latex glove maker, said in a media briefing that it had not yet seen any cancellation of orders, and that it expected the virus outbreak among its workers to be contained within a month.
30/11/2020 3:54 PM
Goku88 Kossan + Supermx remained in MSCI list.
30/11/2020 5:20 PM
Kossan Fresh from TA securities

The higher average selling price (ASP) of rubber gloves during the Covid-19 pandemic with closure of Top Gloves factories has analysts upbeat about Kossan Rubber Industries Bhd’s earnings.

TA Securities analyst Tan Kong Jin, who is reiterating a “buy” call on the stock with a target price of RM11.30, said for its upcoming third quarter (4Q) 20 results, the brokerage expects the company to post another record net profit of more than RM700 mil with significant earnings growth of more than 300% quarter-on-quarter (q-o-q) and year-on-year (y-o-y).
01/12/2020 8:18 AM
Kossan Fresh from Kenanga

Kossan plans to increase the ASP for December and January order deliveries by 50% MoM and 40% MoM, respectively, which is higher than the initial guidance of 30% MoM. Spot prices also increased in tandem with normal prices, from US$80-130 per 1,000 pcs to US$100-150. Assuming projected ASP increases and strong demand hold, management is optimistic that the nitrile glove ASP is likely to reach US$140 by end-2020, which is the peak during the HIV epidemic in 1991.
Views on post-Covid-19 ASP. Mgmt. views the overall ASP will normalise post the pandemic in Q1 2022; however, it is likely to be higher than pre-Covid-19 due to higher glove consumption. Historically, with higher glove demand, manufacturers have enjoyed better negotiating power with customers. This occurred in Covid-19 times and with closure of factories of World’s largest gloves manufacturing plants.
01/12/2020 9:19 AM
fofo Three new clusters detected today
Dr Noor Hisham also announced three new Covid-19 clusters today with 54 total infections.
The three new clusters:
• Jalan Lapan cluster involving Hulu Langat in Selangor as well as Cheras, Kepong, Titiwangsa and Lembah Pantai in Kuala Lumpur (25 cases)
• Batu Sembilan cluster which spans Kuala Langat, Klang, Petaling and Kuala Selangor in Selangor (19 cases)
• Nibong cluster in Johor Bahru, Johor (10 cases)
01/12/2020 2:54 PM
Kossan Fresh from The Sun

Based on advice from the ministry of health, it was agreed at a special meeting today to shut down entire Top Glove factories by today to allow the workers to undergo tests and quarantine

Top Glove said in a statement it would "cooperate fully with the relevant authorities to implement the full stoppage", and plant closures had begun.
01/12/2020 2:57 PM
JimYeoh waiting at 5 now
01/12/2020 4:15 PM
Ukga So far, all the good news mentioned have yet to translate into higher share prices. There are a lot of appetite for other counters instead. Investors sentiment come into play for now. Enjoy trading and stay safe.
01/12/2020 6:53 PM
WeLoveSarawak the Sun in (kossan) has left...now left KO only...lol..
01/12/2020 9:52 PM
Random1121 Profit is so high and share price not moving at all. Price dropping is so much higher
02/12/2020 10:29 AM
Ukga https://www.bbc.co.uk/news/health-55145696

Here come the vaccine. Slowly but surely will reach other parts of the world by next year. Enjoy reading and stay safe.
02/12/2020 7:57 PM
aoisky https://www.theedgemarkets.com/article/nitrile-latex-could-hit-alltime-high-month-raising-glove-production-costs-70-qoq-%E2%80%94-kaf

From Buy to Hold TP @ RM 6.51
03/12/2020 12:09 AM
shinrei kossan forum so lonely now. everyone had left. huhuhuhu
03/12/2020 12:52 AM
xcu843 The next few months of the Covid-19 pandemic will be among “the most difficult in the public health history of this nation,” Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, said Wednesday.

Redfield, speaking at an event hosted by the U.S. Chamber of Commerce, said that about 90% of hospitals in the country are in “hot zones and the red zones.” He added that 90% of long-term care facilities are in areas with high level of spread.

“So we are at a very critical time right now about being able to maintain the resilience of our health-care system,” Redfield said. “The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult in the public health history of this nation, largely because of the stress that’s going to be put on our health-care system.”
03/12/2020 7:52 AM
PZOGRO HOT!

SUPERMAX IN!

KOSSAN NOT IN!!

FBMKLCI GLOVES WEIGHTING UP!!!

TRUELY BIG3: TOPGLOVE; HARTA; SUPERMAX!!!
03/12/2020 3:02 PM
fofo The number of active cases, which carry high transmission risks, rose to 10,802 from 10,686 recorded on Wednesday. This means 116 patients are currently being treated in intensive care units, with 46 needing ventilators to breathe.As of today, Malaysia reported a total of 69,095 Covid-19 cases and 376 deaths.
03/12/2020 9:52 PM
fishchu The big four glove makers have also reported more than double earnings growth on a quarterly basis — Top Glove Corp Bhd (+238.5% q-o-q), Kossan Rubber Industries Bhd (+166.1% q-o-q), Hartalega Holdings Bhd (+148.02% q-o-q) and Supermax Corp Bhd (+97.6% q-o-q).
03/12/2020 10:25 PM
shinrei sad kossan not in with Big 3
03/12/2020 11:36 PM
Kossan Fresh from Kenanga

KOSSAN Rubber Industries Bhd’s noted that higher demand and pricing power from closure of Top glove factories will enable it to post stellar earnings for its upcoming fourth quarter ended 2020 with net profit expected to rise 929% year-on-year (YoY) to RM977.74 million as improvement was recorded across all three divisions — gloves, technical rubber products (TRPs) and cleanroom and safety business.

Revenue for the quarter Is expected to increase by 294.51% YoY to RM 2 billion. According to Kossan, the expected improved performance was mainly attributed to the higher volume sold (234.9%) and much higher average selling price (ASP) compared to 3Q20.
04/12/2020 1:02 AM
mindofgain Among all glove counter, here is most peaceful
04/12/2020 1:19 AM
PanjiAlam55 Go up to little but going down so much,, have to sell and leave this KOSSAN forum soon,,no point to keep it, as this stock no profit at all..so sad...to many fake news on this stock. Bye bye
04/12/2020 3:59 AM
mf [SINGAPORE] American biotechnology company Moderna has asked the authorities in Singapore to approve the use of its Covid-19 vaccine here.

If all goes well, the first vaccine could arrive as early as this month (Dec).
04/12/2020 4:30 AM
Kossan Fresh from Reuters

Malaysia's rubber glove makers are struggling to meet soaring demand for medical gloves during the pandemic due to a closure of Top gloves factories and suspected cases in Supermax factories, the industry's trade association said on Friday, adding that it could cost the country dearly in export revenue.

The Malaysian Rubber Glove Manufacturers Association (MARGMA) estimated that the industry could have lost around 7.6 billion ringgit ($1.85 billion) revenue for Malaysia due to unprecedented shutdowns.
04/12/2020 8:49 AM
Aimhigh Take a look at Hengyuan
04/12/2020 9:20 AM
Aimhigh Rising steadily, good fundamentals
04/12/2020 9:30 AM
Aimhigh Anyone bought Hengyuan this morning? It's the next rocket. Gloves will be suppressed till don't know when
04/12/2020 12:47 PM
Kossan Hengyuan Refining Company Bhd’s net loss narrowed in the third quarter ended Sept 30, 2020 to RM11.43 million from RM122.49 million a year earlier, due to higher revenue.

Loss per share fell to to 3.81 sen from 40.83 sen, the group said in a filing today.

Hengyuan said revenue for the quarter jumped 56% to RM3.23 billion from RM2.07 billion a year ago, as the refinery recorded sales volume of 10.7 million barrels.
04/12/2020 1:37 PM